Skip to main content
  • Français
    • Nederlands
    • English

Home
  • Sign In
  • Domaines thérapeutiques
    • Cardiologie
      • ASCVD
      • Insuffisance Cardiaque
    • Dermatologie
      • Urticaire
    • Hématologie
      • PTI
    • Neurologie
      • Sclérose en plaques
    • Oncologie
      • Cancer du sein
      • Prostate Cancer (mCRPC)
    • Ophtalmologie
      • Maladies de la rétine
    • Respiratoire
    • Rhumatologie
  • Congrès et évenements
    • Cardiologie
      • BSC
      • ESC
    • Dermatologie
      • EADV
      • Sharing is Caring
    • Hématologie
      • ASH
      • EHA
      • ESH
    • Neurologie
      • CMSC
      • EAN
      • ECTRIMS
    • Oncologie
      • ASCO
      • EBCC
      • ESMO
      • SABCS
    • Rhumatologie
      • Sharing is Caring
  • Contactez-nous

Popular Search

  • improved
  • improving
  • aimovig
  • migration
  • migraine

Recent News

Page protected by password
Netelroos - Doe the test
Behandelingen Netelroos
Search
  • Safety Profile

    The most commonly reported adverse reactions were upper respiratory tract infection (18.9%), headache (18.3%) and diarrhoea (11.0%). The most commonly reported serious adverse reaction was urinary tract infection (1.2%) 1 .

    Twitter Linkedin Facebook Pinterest Google plus
  • Safety profile

    Twitter Linkedin Facebook Pinterest Google plus
  • Safety Profile - Entresto

    ENTRESTO ® demonstrated comparable safety and tolerability vs Enalapril
    Twitter Linkedin Facebook Pinterest Google plus
  • Safety Profile - Kesimpta

    Twitter Linkedin Facebook Pinterest Google plus
  • Safety Profile

    As with every medicine, when using REVOLADE, side effects can occur. In the case of serious side effects, it is possible that a dose adjustment is necessary. See also the Summary of Product Characteristics for a full overview of the side effects and side...
    Twitter Linkedin Facebook Pinterest Google plus
  • Safety Profile - Jakavi

    Below is a selection of the observed side effects; please refer to the SmPc or the package leaflet for the complete list.

    Myelosuppression

    Patients who develop anaemia may need blood transfusions. Dose adjustment or...
    Twitter Linkedin Facebook Pinterest Google plus
  • Safety Profile

    Twitter Linkedin Facebook Pinterest Google plus
  • Safety profile - Cosentyx PsA

    Twitter Linkedin Facebook Pinterest Google plus
  • Safety profile

    Twitter Linkedin Facebook Pinterest Google plus
  • Highlights From ASCO 2022

    Ribociclib Breast Cancer Presentations

    MONALEESA-2 OS BY DOSE REDUCTION poster discussion | Hart LL In this exploratory analysis of ML-2, 1L RIB + LET maintained OS benefit in postmenopausal pts with HR+, HER2...
    Twitter Linkedin Facebook Pinterest Google plus
page 

Pages

  • 1
  • 2
 of  2
  • next

Filter by spécialité:

S’abonner à Novartis

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Plan du site
Cookie Settings
©2025 Novartis Belgique & Luxembourg
  • Conditions d'utilisation
  • Politique de protection des données personnelles
  • Cookies
Ce site Internet s’adresse aux professionnels de la santé basés en Belgique & Luxembourg